842
Views
24
CrossRef citations to date
0
Altmetric
Drug Evaluations

Ustekinumab: targeting the IL-17 pathway to improve outcomes in psoriatic arthritis

, MD & , MD MPH

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yuki Nanke, Tsuyoshi Kobashigawa, Naoki Sugimoto, Hisashi Yamanaka & Shigeru Kotake. (2019) A case of psoriatic arthritis, with joint involvement preceding skin involvement, successfully treated with adalimumab (80 mg every other week). Immunological Medicine 42:2, pages 99-102.
Read now
Renata Baronaite Hansen & Arthur Kavanaugh. (2016) Secukinumab for the treatment of psoriatic arthritis. Expert Review of Clinical Immunology 12:10, pages 1027-1036.
Read now

Articles from other publishers (22)

P. Lindsø Andersen, G. B. Jemec, C. Erikstrup, M. Didriksen, K. M. Dinh, S. Mikkelsen, E. Sørensen, K. R. Nielsen, M. T. Bruun, H. Hjalgrim, T. F. Hansen, S. G. Sækmose, S. R. Ostrowski, D. M. L. Saunte & O. B. Pedersen. (2022) Human leukocyte antigen system associations in Malassezia-related skin diseases. Archives of Dermatological Research 315:4, pages 895-902.
Crossref
Eva Galíndez-Agirregoikoa, Diana Prieto-Peña, José Luis Martín-Varillas, Beatriz Joven, Olga Rusinovich, Rafael B. Melero-González, Francisco Ortiz-Sanjuan, Raquel Almodóvar, Juan José Alegre-Sancho, Ángels Martínez, Agustí Sellas-Fernández, Lara Méndez, Rosario García-Vicuña, Belén Atienza-Mateo, Iñigo Gorostiza, Miguel Ángel González-Gay & Ricardo Blanco. (2021) Treatment With Tofacitinib in Refractory Psoriatic Arthritis: A National Multicenter Study of the First 87 Patients in Clinical Practice. The Journal of Rheumatology 48:10, pages 1552-1558.
Crossref
Rohan Shah, Merav Koschitzky & Saakshi Khattri. (2021) Psoriatic arthritis—What we know now?. Dermatological Reviews 2:5, pages 229-235.
Crossref
Yong Eun Park & Tae Oh Kim. (2020) Sexual Dysfunction and Fertility Problems in Men with Inflammatory Bowel Disease. The World Journal of Men's Health 38:3, pages 285.
Crossref
Erwin Dreesen & Ann Gils. (2019) Pharmacodynamic Monitoring of Biological Therapies in Chronic Inflammatory Diseases. Therapeutic Drug Monitoring 41:2, pages 131-141.
Crossref
Entcho Klenske, Lourdes Osaba, Daniel Nagore, Timo Rath, Markus F Neurath & Raja Atreya. (2019) Drug Levels in the Maternal Serum, Cord Blood and Breast Milk of a Ustekinumab-Treated Patient with Crohn’s Disease. Journal of Crohn's and Colitis 13:2, pages 267-269.
Crossref
P. Gisondi, G. Altomare, F. Ayala, A. Conti, P. Dapavo, C. De Simone, C. Foti, L. Idolazzi, E. Lubrano, G. Malara, A. Marchesoni, I. Olivieri, A. Parodi, K. Peris, S. Piaserico, C. Salvarani, R. Scarpa & G. Girolomoni. (2018) Consensus on the management of patients with psoriatic arthritis in a dermatology setting. Journal of the European Academy of Dermatology and Venereology 32:4, pages 515-528.
Crossref
X. Cortes, J. Borrás-Blasco, B. Antequera, S. Fernandez-Martinez, E. Casterá, S. Martin & J. R. Molés. (2017) Ustekinumab therapy for Crohn's disease during pregnancy: a case report and review of the literature. Journal of Clinical Pharmacy and Therapeutics 42:2, pages 234-236.
Crossref
Christopher T. Ritchlin, Robert A. Colbert & Dafna D. Gladman. (2017) Psoriatic Arthritis. New England Journal of Medicine 376:10, pages 957-970.
Crossref
Joaquín Borrás-Blasco, Xavier Cortes, Sergio Fernandez-Martinez, Elvira Casterá & Beatriz Antequera. (2017) Legionella pneumophila pneumonia possibly due to ustekinumab therapy in a patient with Crohn’s disease . American Journal of Health-System Pharmacy 74:4, pages 209-212.
Crossref
Helen Alexander & Frank O. Nestle. (2017) Pathogenesis and immunotherapy in cutaneous psoriasis: what can rheumatologists learn?. Current Opinion in Rheumatology 29:1, pages 71-78.
Crossref
Ananta Paine & Christopher T. Ritchlin. (2016) Targeting the interleukin-23/17 axis in axial spondyloarthritis. Current Opinion in Rheumatology 28:4, pages 359-367.
Crossref
Christopher T. Ritchlin & James G. Krueger. (2016) New therapies for psoriasis and psoriatic arthritis. Current Opinion in Rheumatology 28:3, pages 204-210.
Crossref
Fabrizio Cantini, Laura Niccoli, Carlotta Nannini, Emanuele Cassarà, Olga Kaloudi, Ennio Giulio Favalli, Andrea Becciolini, Martina Biggioggero, Maurizio Benucci, Francesca Li Gobbi, Valentina Grossi, Maria Infantino, Francesca Meacci, Mariangela Manfredi, Serena Guiducci, Silvia Bellando-Randone, Marco Matucci-Cerinic, Rosario Foti, Marcella Di Gangi, Marta Mosca, Chiara Tani, Fabrizio Palmieri & Delia Goletti. (2016) Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis. Seminars in Arthritis and Rheumatism 45:5, pages 519-532.
Crossref
Kevin D. Pile, Garry G. Graham & Stephen M. Mahler. 2016. Compendium of Inflammatory Diseases. Compendium of Inflammatory Diseases 714 717 .
Fabiola Atzeni, Ignazio F Masala, Laura Boccassini & Piercarlo Sarzi-Puttini. (2015) Early psoriatic arthritis: should we treat it in the same way as we treat rheumatoid arthritis?. International Journal of Clinical Rheumatology 10:6, pages 399-408.
Crossref
Tiago Torres & Raquel Faria. (2015) Ustekinumab: The “New Kid on the Block” in the Treatment of Psoriatic Arthritis. Drug Development Research 76:8, pages 428-431.
Crossref
Mahta Mortezavi & Christopher Ritchlin. (2015) IL12/IL23 Inhibition in the Treatment of Psoriatic Arthritis. Current Treatment Options in Rheumatology 1:2, pages 197-209.
Crossref
Suzanne J. Tintle & Alice B. Gottlieb. (2015) Psoriatic Arthritis for the Dermatologist. Dermatologic Clinics 33:1, pages 127-148.
Crossref
Kevin D. Pile, Garry G Graham & Stephen M. Mahler. 2015. Encyclopedia of Inflammatory Diseases. Encyclopedia of Inflammatory Diseases 1 3 .
Ian C. Scott, James B. Galloway & David L. ScottIan C. Scott, James B. Galloway & David L. Scott. 2015. Inflammatory Arthritis in Clinical Practice. Inflammatory Arthritis in Clinical Practice 137 153 .
Kate McKeage. (2014) Ustekinumab: A Review of Its Use in Psoriatic Arthritis. Drugs 74:9, pages 1029-1039.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.